SAE Media Group’s 5th Annual Conference
Pharmaceutical Microbiology East Coast
April 27-28 2022 | Boston, US
--------------------------------------------------------------------------------------------------------------------------------------------------
Microbiology remains an essential tool in reducing microbial growth in the manufacture of pharmaceuticals, to detect and eliminate microorganisms that would pose a risk to patients and jeopardise product batches.
Ensuring the sterility of the finished product continues to be one of the most critical aspects of drug development, however an array of factors are also sustaining new growth and transformation in this field. The regulatory landscape is changing, firstly with the preparation of Annex I, in addition to increasing requirements pertaining to data integrity. Light is being shed on recent product recalls for mould contamination, and infection outbreaks serve as a reminder to pay more attention to these overlooked organisms, as well as considerations towards container closure integrity testing which is being increasingly deployed to block microbe movement.
This workshop will be interactive while sharing the latest revisions and proposed revisions from the USP Microbiology Expert Committee. Some areas that will be discussed are sterilization, disinfectant efficacy testing, bacterial endotoxins test, B. cepacia test, microbial ‘sterility’ test for ATMPs, and microbiology best laboratory practices.
Bring your questions and learn how to use/interpret the USP microbiological information and standards with a member of the Expert Committee.
To register your interest or to get involved please contact: eshambler@SAE Media Group-online.co.uk